Company Page

Changed Risks for RESMED INC (RMD)

Our results of operations may be materially affected by global economic conditions generally, including conditions in the financial markets

We are subject to various risks relating to international activities that could affect our overall profitability

RESMED INC AND SUBSIDIARIES

We are subject to substantial regulation related to quality standards applicable to our manufacturing and quality processes Our failure to comply with these standards could have an adverse effect on our business, financial condition, or results of operations

Our business activities are subject to extensive regulation, and any failure to comply could have a materially adverse effect on our business, financial condition, or results of operations

Our business depends on our ability to market effectively to dealers of home healthcare products and sleep clinics

Government and private insurance plans may not adequately reimburse our customers for our products, which could result in reductions in sales or selling prices for our products

Product sales, introductions or modifications may be delayed or canceled as a result of FDA regulations or similar foreign regulations, which could cause our sales and profits to decline

Actual or attempted breaches of security, unauthorized disclosure of information, denial of service attacks or the perception that personal and/or other sensitive or confidential information in our possession is not secure, could result in a material loss of business, substantial legal liability or significant harm to our reputation

If we fail to integrate our acquisitions with our operations, our business could suffer

Tax laws, regulations, and enforcement practices are evolving and may have a material adverse effect on our results of operations, cash flows and financial position

We are subject to tax audits by various tax authorities in many jurisdictions

We may write-off intangible assets, such as goodwill 

If a natural or man-made disaster strikes our manufacturing facilities, we will be unable to manufacture our products for a substantial amount of time and our sales and profitability will decline

Healthcare reform may have a material adverse effect on our industry and our results of operations 

We are increasingly dependent on information technology systems and infrastructure

Off-label marketing of our products could result in substantial penalties

If we are unable to support our continued growth, our business could suffer

Disruptions in the supply of components from our suppliers could result in a significant reduction in sales and profitability

Our products are the subject of clinical trials conducted by us, our competitors, or other third parties, the results of which may be unfavorable, or perceived as unfavorable, and could have a material adverse effect on our business, financial condition, and results of operations

Laws regulating consumer contacts could adversely affect our business operations or create liabilities

Delaware law and provisions in our charter and could make it difficult for another company to acquire us

Our quarterly operating results are subject to fluctuation for a variety of reasons

Failure to comply with anti-kickback and fraud regulations could result in substantial penalties and changes in our business operations

Consolidation in the health care industry could have an adverse effect on our revenues and results of operations

We are subject to potential product liability claims that may exceed the scope and amount of our insurance coverage, which would expose us to liability for uninsured claims

Our inability to compete successfully in our markets may harm our business